The largest shareholder of Spacelabs Medical Inc. has urged the company to consider a $143 million offer made last November by Cardiac Science Inc. But at least two analysts predicted Spacelabs won’t likely see a takeout at all. Tweedy, Browne Co. LLC, a 13% owner, said in a Dec. 28 letter that it supports a sale of the company. It drew attention to the $15-per-share bid and encouraged Spacelabs to negotiate with Cardiac. When contacted, Tweedy declined comment. After Cardiac announced its lastest bid on Nov. 27, Spacelabs retained UBS Warburg to explore strategic options. It could not be determined, however, when exactly the company hired UBS.
To read the entire story, you must be logged in.
Please log in now or register with us.
